More than one in five people are unable to name any symptoms of the world’s biggest cancer killer, according to a survey.
The research, which was carried out by Ipsos MORI on behalf of the Global Lung Cancer Coalition, investigated awareness of the symptoms of lung cancer and smoking prevalence in 21 countries.
Researchers found that across all the countries, 22% of people surveyed admitted they could not name any symptoms of the disease, which claims the lives of 1.37 million people globally every year.
The research, which surveyed over 17,000 people, also found that former smokers are slightly more likely to be aware of symptoms than current smokers or people who have never smoked.
Dr Matthew Peters, chair of The Global Lung Cancer Coalition, which is made up of 31 non-government patient organisation across the globe, said: "Patients are often diagnosed with lung cancer at a very late stage when treatment is no longer an option.
“If we can get patients diagnosed earlier, we can treat them and save lives. That is why being aware of the symptoms is so important.
“It is shocking to think that almost a quarter of people can not name any symptoms of the world’s biggest cancer killer.
In many countries Lung Cancer Awareness Month takes place in November.
It aims to achieve better outcomes for lung cancer patients and their families through:
raising public awareness of lung cancer
educating those at risk about symptoms and early presentation
signposting sources of information and support
placing lung cancer firmly on the agenda of healthcare authorities
Late stage diagnosis, poor survival outcomes and few treatment choices make lung cancer a particularly devastating and emotional disease for people to deal with.
There are many negative perceptions and stigmas surrounding the disease, which indirectly impact on funding, resources and how individuals view the condition.
Click here to view our members' websites and find out what is happening in your country this November.
Click here to download our lung cancer awareness leaflets.
Global Lung Cancer Coaltion
The GLCC is the international 'voice' of lung cancer patients. Established in 2001, the GLCC comprises 30 non-government patient organisations from Argentina, Australia, Bulgaria, Canada, Denmark, Egypt, France, Germany, Ireland, Italy, Japan, Netherlands, Norway, Portugal, Slovenia, Spain, Sweden, Switzerland, UK and US.